ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.

ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.

Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to morbidity and mortality. Effective treatment of OSA with continuous positive airway pressure (CPAP) could prevent...

Detaylı Bibliyografya
Asıl Yazarlar:	Schlatzer, C, Bratton, D, Craig, S, Kohler, M, Stradling, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	BMJ Publishing Group 2016

Benzer Materyaller

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
Yazar:: Craig, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
Yazar:: Craig, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea.
Yazar:: Schulz, U, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.
Yazar:: Bratton, D, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea.
Yazar:: Ayers, L, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Intrathoracic pressure swings induced by simulated obstructive sleep apnoea promote arrhythmias in paroxysmal atrial fibrillation
Yazar:: Schlatzer, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
Yazar:: Craig, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

S3 Effect of continuous positive airway pressure on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials
Yazar:: Bratton, D, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
Yazar:: Schwarz, E, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Mild To Moderate, Minimally Symptomatic, Obstructive Sleep Apnoea (OSA) Is Associated With 'Vulnerable' Carotid Atherosclerotic Plaques
Yazar:: Craig, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Predictors of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial.
Yazar:: Turnbull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Patterns of CPAP usage in patients with minimally symptomatic OSA
Yazar:: Turnbull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Mechanisms of Atrial Fibrillation in Obstructive Sleep Apnoea
Yazar:: James Saleeb-Mousa, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
Yazar:: Tang, I, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial.
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial
Yazar:: Craig, S, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis
Yazar:: Schwarz, E, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis.
Yazar:: Schwarz, E, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Obstructive sleep apnoea and atrial fibrillation: are we on time?!
Yazar:: Elisa Perger, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
Yazar:: John R Stradling, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Cardiac remodelling in patients with atrial fibrillation and obstructive sleep apnoea
Yazar:: Lars Gullestad, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea.
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Predictors Of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial
Yazar:: Turnbull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Obstructive sleep apnoea.
Yazar:: Stradling, J
Baskı/Yayın Bilgisi: (2007)

Effects of obstructive sleep apnoea on heart rhythm.
Yazar:: Rossi, V, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Pharmacological approaches to the treatment of obstructive sleep apnoea.
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Endothelial function in patients with mild moderate obstructive sleep apnoea
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Circulating Cell-Derived Microparticles in Patients with Minimally Symptomatic Obstructive Sleep Apnea
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring.
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The phenotype of obstructive sleep apnoea
Yazar:: Stradling, J
Baskı/Yayın Bilgisi: (2008)

Obstructive sleep apnoea and driving.
Yazar:: Stradling, JR
Baskı/Yayın Bilgisi: (1989)

Driving and obstructive sleep apnoea.
Yazar:: Stradling, J
Baskı/Yayın Bilgisi: (2008)

Obstructive sleep apnoea syndrome.
Yazar:: Stradling, JR
Baskı/Yayın Bilgisi: (1982)

PREDICTION OF ATRIAL FIBRILLATION RECURRENCE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION SUFFERING FROM OBSTRUCTIVE SLEEP APNOEA/HYPOPNOEA SYNDROME
Yazar:: Balabanovich T. I., ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP
Yazar:: Turnbull, CD, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Circulating cell-derived microparticles in patients with mild obstructive steep apnoea
Yazar:: Ayers, L, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

TWO YEAR VASCULAR EVENT, HOSPITAL ADMISSIONS, AND ACCIDENT INCIDENCE: FURTHER DATA FROM THE MOSAIC SLEEP APNOEA TRIAL
Yazar:: Turnbull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea
Yazar:: Turnbull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Pitfalls of clinical trials on pharmacological treatment for obstructive sleep apnoea: future directions.
Yazar:: Kohler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)